A detailed history of New York State Common Retirement Fund transactions in Precigen, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 38,038 shares of PGEN stock, worth $25,485. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,038
Previous 38,038 -0.0%
Holding current value
$25,485
Previous $60,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$1.27 - $1.75 $1,230 - $1,695
969 Added 2.61%
38,038 $60,000
Q1 2024

May 07, 2024

SELL
$1.21 - $1.75 $32,637 - $47,202
-26,973 Reduced 42.12%
37,069 $54,000
Q4 2023

Feb 01, 2024

SELL
$0.89 - $1.41 $149 - $236
-168 Reduced 0.26%
64,042 $86,000
Q3 2023

Nov 07, 2023

BUY
$1.08 - $1.85 $551 - $945
511 Added 0.8%
64,210 $91,000
Q1 2023

May 02, 2023

SELL
$0.88 - $2.19 $1,496 - $3,723
-1,700 Reduced 2.6%
63,699 $68,000
Q4 2022

Jan 30, 2023

SELL
$1.27 - $2.26 $10 - $18
-8 Reduced 0.01%
65,399 $99,000
Q3 2022

Nov 08, 2022

BUY
$1.41 - $2.79 $414 - $820
294 Added 0.45%
65,407 $139,000
Q2 2022

Aug 04, 2022

SELL
$1.15 - $2.53 $250 - $551
-218 Reduced 0.33%
65,113 $87,000
Q1 2022

May 05, 2022

BUY
$1.91 - $3.98 $7 - $15
4 Added 0.01%
65,331 $138,000
Q4 2021

Feb 02, 2022

SELL
$3.53 - $5.5 $2.83 Million - $4.41 Million
-802,419 Reduced 92.47%
65,327 $242,000
Q3 2021

Nov 02, 2021

SELL
$4.99 - $6.55 $81,277 - $106,686
-16,288 Reduced 1.84%
867,746 $4.33 Million
Q2 2021

Aug 02, 2021

BUY
$6.24 - $8.22 $158,508 - $208,804
25,402 Added 2.96%
884,034 $5.76 Million
Q1 2021

May 11, 2021

BUY
$6.74 - $10.95 $5.41 Million - $8.78 Million
802,232 Added 1422.4%
858,632 $5.92 Million
Q1 2020

May 06, 2020

BUY
$1.46 - $7.19 $82,344 - $405,516
56,400 New
56,400 $192,000

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $139M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.